374 related articles for article (PubMed ID: 11689212)
1. Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.
Tertov VV; Kaplun VV; Sobenin IA; Boytsova EY; Bovin NV; Orekhov AN
Atherosclerosis; 2001 Nov; 159(1):103-15. PubMed ID: 11689212
[TBL] [Abstract][Full Text] [Related]
2. Human plasma trans-sialidase donor and acceptor specificity.
Tertov VV; Nikonova EY; Nifant'ev NE; Bovin NV; Orekhov AN
Biochemistry (Mosc); 2002 Aug; 67(8):908-13. PubMed ID: 12223090
[TBL] [Abstract][Full Text] [Related]
3. Specificity of human trans-sialidase as probed with gangliosides.
Nikonova EY; Tertov VV; Sato C; Kitajima K; Bovin NV
Bioorg Med Chem Lett; 2004 Oct; 14(20):5161-4. PubMed ID: 15380219
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
[TBL] [Abstract][Full Text] [Related]
5. The action of Trypanosoma cruzi trans-sialidase on glycolipids and glycoproteins.
Ferrero-García MA; Trombetta SE; Sánchez DO; Reglero A; Frasch AC; Parodi AJ
Eur J Biochem; 1993 Apr; 213(2):765-71. PubMed ID: 8477749
[TBL] [Abstract][Full Text] [Related]
6. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
[TBL] [Abstract][Full Text] [Related]
7. Selective ganglioside desialylation in the plasma membrane of human neuroblastoma cells.
Kopitz J; von Reitzenstein C; Sinz K; Cantz M
Glycobiology; 1996 Apr; 6(3):367-76. PubMed ID: 8724144
[TBL] [Abstract][Full Text] [Related]
8. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients.
Orekhov AN; Tertov VV; Mukhin DN; Mikhailenko IA
Biochem Biophys Res Commun; 1989 Jul; 162(1):206-11. PubMed ID: 2751649
[TBL] [Abstract][Full Text] [Related]
9. The developmentally regulated trans-sialidase from Trypanosoma brucei sialylates the procyclic acidic repetitive protein.
Engstler M; Reuter G; Schauer R
Mol Biochem Parasitol; 1993 Sep; 61(1):1-13. PubMed ID: 8259122
[TBL] [Abstract][Full Text] [Related]
10. Mediation of Trypanosoma cruzi invasion by sialic acid on the host cell and trans-sialidase on the trypanosome.
Ming M; Chuenkova M; Ortega-Barria E; Pereira ME
Mol Biochem Parasitol; 1993 Jun; 59(2):243-52. PubMed ID: 8341323
[TBL] [Abstract][Full Text] [Related]
11. Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.
Cheng J; Yu H; Lau K; Huang S; Chokhawala HA; Li Y; Tiwari VK; Chen X
Glycobiology; 2008 Sep; 18(9):686-97. PubMed ID: 18509108
[TBL] [Abstract][Full Text] [Related]
12. Substrate specificity and inhibitor studies of a membrane-bound ganglioside sialidase isolated from human brain tissue.
Oehler C; Kopitz J; Cantz M
Biol Chem; 2002 Nov; 383(11):1735-42. PubMed ID: 12530538
[TBL] [Abstract][Full Text] [Related]
13. Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein.
Tertov VV; Sobenin IA; Orekhov AN
Free Radic Res; 1996 Oct; 25(4):313-9. PubMed ID: 8889495
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties.
Sukhorukov V; Gudelj I; Pučić-Baković M; Zakiev E; Orekhov A; Kontush A; Lauc G
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):643-653. PubMed ID: 30641224
[TBL] [Abstract][Full Text] [Related]
15. Sialic acid-containing components of lipoproteins influence lipoprotein-proteoglycan interactions.
Millar JS; Anber V; Shepherd J; Packard CJ
Atherosclerosis; 1999 Aug; 145(2):253-60. PubMed ID: 10488950
[TBL] [Abstract][Full Text] [Related]
16. A Pasteurella multocida sialyltransferase displaying dual trans-sialidase activities for production of 3'-sialyl and 6'-sialyl glycans.
Guo Y; Jers C; Meyer AS; Arnous A; Li H; Kirpekar F; Mikkelsen JD
J Biotechnol; 2014 Jan; 170():60-7. PubMed ID: 24291191
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of low density lipoprotein isolated from circulating immune complexes.
Tertov VV; Sobenin IA; Orekhov AN; Jaakkola O; Solakivi T; Nikkari T
Atherosclerosis; 1996 May; 122(2):191-9. PubMed ID: 8769682
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic properties of sialidase from the ovary of the starfish, Asterina pectinifera.
Iriyama N; Takeuchi N; Shiraishi T; Izumi K; Sawada MT; Takahashi N; Furuhata K; Ogura H; Uda Y
Comp Biochem Physiol B Biochem Mol Biol; 2000 Aug; 126(4):561-9. PubMed ID: 11026668
[TBL] [Abstract][Full Text] [Related]
19. Chemoenzymatic synthesis of Neu5Ac9NAc-containing α2-3- and α2-6-linked sialosides and their use for sialidase substrate specificity studies.
Li W; Xiao A; Li Y; Yu H; Chen X
Carbohydr Res; 2017 Nov; 451():51-58. PubMed ID: 28961426
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a recombinant Bacteroides fragilis sialidase expressed in Escherichia coli.
Yamamoto T; Ugai H; Nakayama-Imaohji H; Tada A; Elahi M; Houchi H; Kuwahara T
Anaerobe; 2018 Apr; 50():69-75. PubMed ID: 29432848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
